Enron Mail

From:james.new@enron.com
To:steven.leppard@enron.com
Subject:Re: Research sign off
Cc:tani.nath@enron.com, ted.murphy@enron.com, vince.kaminski@enron.com
Bcc:tani.nath@enron.com, ted.murphy@enron.com, vince.kaminski@enron.com
Date:Mon, 29 Jan 2001 07:49:00 -0800 (PST)

I totally agree. What you list is all we are after.





Steven Leppard
29/01/2001 15:45
To: James New/LON/ECT@ECT
cc: Tani Nath/LON/ECT@ECT, Ted Murphy/LON/ECT@ECT, Vince J
Kaminski/HOU/ECT@ECT

Subject: Re: Research sign off

James

I agree with what you say - my view is that Research can:
- assess a model;
- state what the model does;
- give a view of how closely the model achieves its objectives;
- assess what the risks of using the model are.

It is for RAC to determine whether Enron is prepared to accept this risk. I
discussed this issue with Ted, and he seems to agree with this broad
splitting of responsibilities.

Steve



James New
29/01/2001 13:59
To: Steven Leppard/LON/ECT@ECT
cc: Sharad Agnihotri/LON/ECT@ECT, Tani Nath/LON/ECT@ECT, Ted
Murphy/LON/ECT@ECT, Vince J Kaminski/HOU/ECT@ECT

Subject: Re: Research sign off

Steve,

I understand your comments but the 'sign off' is a cross functional thing and
research are effectively only being asked to sign off their part which is
broadly as you describe below. If you have doubts as to the interpretation of
a research sign off then it should be qualified to state what you are
prepared to sign off on. Other functions should be asked to do like wise for
their area which will mean that when all areas have signed off their part
the picture is complete. Somebody needs to coordinate this and usually in
London it is the Risk Management guy.

Does this make sense ?





Steven Leppard
24/01/2001 09:42
To: Sharad Agnihotri/LON/ECT@ECT
cc: Tani Nath/LON/ECT@ECT, Ted Murphy/LON/ECT@ECT, James New/LON/ECT@ECT,
Vince J Kaminski/HOU/ECT@ECT

Subject: Research sign off

Hi Sharad

I note from our discussion earlier this morning that you've been asked to
sign off a calculation from another group, which is something we're asked to
do from time to time.

I take the view that we in Research can assess a computation in terms of what
it achieves with respect to its requirements, what its shortfalls are, and
therefore what the risks associated with using this method are. We cannot
provide an opinion on whether these risks are acceptable to Enron, which I
feel falls firmly within RAC territory.

This then raises the question of can Research sign off anything for other
groups after all? To "sign off" means to accept something, which our opinion
in itself cannot do. It is most appropriate for us to provide a technical
note outlining the methodology, risks and shortcomings of a method, leaving
the formal "sign off" to those best placed to assess these risks for our
company. The alternative is for multiple groups each to have their own view
on what is acceptable risk for the company.

Steve